COMMUNITY HEALTH SYSTEMS INC (CYH)

US2036681086 - Common Stock

3.42  +0.13 (+3.95%)

After market: 3.49 +0.07 (+2.05%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to CYH. CYH was compared to 118 industry peers in the Health Care Providers & Services industry. There are concerns on the financial health of CYH while its profitability can be described as average. CYH has a valuation in line with the averages, but on the other hand it scores bad on growth.



Quickly go to:

4

1. Profitability

1.1 Basic Checks

CYH had negative earnings in the past year.
In the past year CYH had a positive cash flow from operations.
In multiple years CYH reported negative net income over the last 5 years.
CYH had a positive operating cash flow in 4 of the past 5 years.

1.2 Ratios

CYH has a Return On Assets (-0.85%) which is in line with its industry peers.
CYH's Return On Invested Capital of 5.98% is fine compared to the rest of the industry. CYH outperforms 69.23% of its industry peers.
The Average Return On Invested Capital over the past 3 years for CYH is below the industry average of 8.58%.
Industry RankSector Rank
ROA -0.85%
ROE N/A
ROIC 5.98%
ROA(3y)0.3%
ROA(5y)-0.05%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)6%
ROIC(5y)5.36%

1.3 Margins

Looking at the Operating Margin, with a value of 7.42%, CYH is in the better half of the industry, outperforming 77.78% of the companies in the same industry.
CYH's Operating Margin has improved in the last couple of years.
CYH's Gross Margin of 84.24% is amongst the best of the industry. CYH outperforms 97.44% of its industry peers.
In the last couple of years the Gross Margin of CYH has remained more or less at the same level.
Industry RankSector Rank
OM 7.42%
PM (TTM) N/A
GM 84.24%
OM growth 3Y12.48%
OM growth 5Y2.07%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.28%
GM growth 5Y0.16%

More info and screens

2

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so CYH is still creating some value.
Compared to 1 year ago, CYH has more shares outstanding
The number of shares outstanding for CYH has been increased compared to 5 years ago.
CYH has about the same debt/assets ratio as last year.

2.2 Solvency

Based on the Altman-Z score of 0.84, we must say that CYH is in the distress zone and has some risk of bankruptcy.
CYH has a Altman-Z score (0.84) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z 0.84
ROIC/WACC1.01
WACC5.89%

2.3 Liquidity

A Current Ratio of 1.49 indicates that CYH should not have too much problems paying its short term obligations.
CYH has a Current ratio (1.49) which is comparable to the rest of the industry.
CYH has a Quick Ratio of 1.33. This is a normal value and indicates that CYH is financially healthy and should not expect problems in meeting its short term obligations.
CYH has a Quick ratio (1.33) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.49
Quick Ratio 1.33

More info and screens

3

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 44.16% over the past year.
Looking at the last year, CYH shows a small growth in Revenue. The Revenue has grown by 2.57% in the last year.
The Revenue has been decreasing by -2.47% on average over the past years.
EPS 1Y (TTM)44.16%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q67.44%
Revenue 1Y (TTM)2.57%
Revenue growth 3Y1.94%
Revenue growth 5Y-2.47%
Revenue growth Q2Q1.03%

3.2 Future

Based on estimates for the next years, CYH will show a very strong growth in Earnings Per Share. The EPS will grow by 36.10% on average per year.
CYH is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.22% yearly.
EPS Next Y69.92%
EPS Next 2Y45.04%
EPS Next 3Y36.1%
EPS Next 5YN/A
Revenue Next Year0.24%
Revenue Next 2Y2.16%
Revenue Next 3Y3.22%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for CYH. In the last year negative earnings were reported.
With a Price/Forward Earnings ratio of 23.72, CYH is valued on the expensive side.
CYH's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. CYH is cheaper than 62.39% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of CYH to the average of the S&P500 Index (20.41), we can say CYH is valued inline with the index average.
Industry RankSector Rank
PE N/A
Fwd PE 23.72

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CYH indicates a rather cheap valuation: CYH is cheaper than 85.47% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 8.46

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as CYH's earnings are expected to grow with 36.10% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y45.04%
EPS Next 3Y36.1%

More info and screens

0

5. Dividend

5.1 Amount

CYH does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

COMMUNITY HEALTH SYSTEMS INC

NYSE:CYH (5/3/2024, 7:04:00 PM)

After market: 3.49 +0.07 (+2.05%)

3.42

+0.13 (+3.95%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap475.28M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 23.72
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.85%
ROE N/A
ROCE
ROIC
ROICexc
ROICexgc
OM 7.42%
PM (TTM) N/A
GM 84.24%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.87
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1.49
Quick Ratio 1.33
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)44.16%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y69.92%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)2.57%
Revenue growth 3Y1.94%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y